Category: Healthcare Finance News

Blue Cross Blue Shield organizations and Civica Rx partner on lower cost generic drugs

The 18 BCBS companies will provide $55 million to help create a Civica subsidiary focused on generic medications outside of the hospital setting.

Cardinal Health recalls millions of surgical gowns due to sterility concerns

The gowns were not registered with the U.S. Food and Drug Administration and were not qualified by Cardinal Health.

Surgeon General releases smoking cessation report outlining strategies for healthcare systems, individuals

Though smoking is at an all-time low of 14%, it remains the leading cause of preventable disease, disability and death in the U.S.

Mergers in 2020 expected to be more strategic than financial in nature

The hospital-to-hospital merger or partnership is about complementary resources put together for the benefit of both, according to KaufmanHall report.

Former Cleveland Clinic CEO Dr. Toby Cosgrove joins CareCentrix as strategic advisor

Under his leadership, Cleveland Clinic’s revenues grew from $3.7 billion in 2004 to $8.5 billion in 2016.

UPDATE: World Health Organization again decides against declaring a global emergency over coronavirus

For providers, travel history is key to determine whether to test for the virus in which symptoms can mirror that of the flu.

Drug supply chain, pricing system reforms will slash healthcare costs, says PRI

An interventionist approach from the government may not work as intended; market competition and systemic reform will be paramount.

Humana, Validic partnership to focus on accessibility of health incentive programs

The collaboration is meant to spur more engagement in the Go360 program by allowing a broad range of wearables and connected devices.

Fewer than half of US clinical trials have complied with the law on reporting results despite new regulations

Trials with non-industry sponsors are far more likely to breach the rules than trials sponsored by industry.

Comparing cancer costs challenging despite new price transparency rules

The lack of common terminology, unbundled cost reporting and listing of non-negotiated rates limits the information’s value.